Abstract
Gallstones are quite prevalent in western countries (10-20% of adult population), but there are very few data about the prevalence of cholecystolithiasis in haemodialysis (HD) patients. In our study, we found--with real-time ultrasound--a prevalence of gallstones of 16% in patients with end-stage renal disease (ESRD) treated with HD which is similar to the prevalence in a non-uraemic control group matched for age and sex. In most of our HD patients, cholecystolithiasis was asymptomatic. HD patients with cholecystolithiasis were statistically significantly older than patients without gallstones. We found no differences in sex or duration of HD treatment in patients with and without cholecystolithiasis. The prevalence of cholecytolithiasis in patients with ESRD on HD is similar to that of a normal population though some data suggested a higher prevalence in HD patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
